 MESSAGE FROM THE DIRECTOR
Medal for Excellence in Health Science Innovation
Many of you have offered congratulations for the Thursday evening announcement that I, representing the Case CCC and the NCRM, had received the School of Medicine Case Western Reserve Medal for Excellence in Health Science Innovation for our efforts in clinical and translational research applications of basic discoveries and in coordinating these efforts across our institutions.
Needless to say I am humbled by the recognition, but also need to acknowledge that first and foremost, this recognition is totally dependent on the good deeds, inspiration, creativity, hard work and good will of the faculty members of the Case CCC and NCRM. We would not have gotten very far if the engagements had turned sour and the trust in the Centers had been lost. Many of you sacrifice your individual passions to pursue interests in collaboration and training that are far more difficult, if arguably not more satisfying, for the benefit of cancer and stem cell research. Collectively our joint efforts prove that the net impact of our research and training is far greater than the sum of its parts.
So, I really applaud all of you for allowing me to represent your interests to the institutions and to gain the recognition for the outstanding work that you do! Tell your friends and colleagues that we have something special here, and could use their engagement and support!
Stan Gerson, MD
Director, Case CCC
CASE CCC IN THE NEWS
Vaccine for Staph More Lethal Than Skin Cancer Tested
Businessweek - Sep 17, 2012
Menachem Shoham, an associate professor of biochemistry at Case Western Reserve University in Cleveland, Ohio, is attempting to outwit the ...
New Cancer Drugs Are Showing Great Promise
U.S. News & World Report - Sep 11, 2012
...Fewer than 10 percent of cancer patients enroll in trials, says Neal Meropol, chief of the division of hematology and oncology at University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine in Cleveland...
Researchers, Oncologists Embrace the 'Concept of a Cure'
HemOnc Today - Sep 10, 2012
"Even after a tumor has been removed for pancreas cancer and the patient receives standard adjuvant therapy – chemotherapy or chemotherapy with radiation – expected survival is generally 18 to 24 months," Jeffrey Hardacre, MD, associate professor of surgery at Case Western University School of Medicine...
FUNDING OPPORTUNITIES
2013 Advanced Clinical Research Award in Breast Cancer
The Conquer Cancer Foundation of the American Society of Clinical Oncology is accepting applications for the Advanced Clinical Research Award (ACRA), a topic-specific competition designed to fund investigators who are committed to clinical cancer research. Past topics have included breast cancer, colorectal cancer, hematological malignancies, lung cancer, and sarcoma. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects.
LOI Deadline: October 22
Full Application Deadline: December 5
Leukemia & Lymphoma Society Specialized Center of Research Program
Applications are currently being accepted for the Leukemia & Lymphoma Society Specialized Center of Research (SCOR) Program. This innovative program supports interdisciplinary research across at least three independent research projects that are integrated and supported by scientific core laboratories. Members of SCOR teams include some of the brightest medical specialists in the field of leukemia, lymphoma and myeloma research-brought together to be part of a highly organized and inspired team approach to speed the discovery of new drugs and curative treatment.
Deadline: November 1
DeGregorio Foundation Award for Cancers of the Upper GI Tract
The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce its third annual funding opportunity for gastroesophageal malignancies. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. It supports high quality, innovative, and transformative translational research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.
Deadline: November 5
Limited Submission: NIH Director's Early Independence Award
The NIH Director's Early Independence Awards provide an opportunity for exceptional junior scientists, who have already established a record of innovation and research productivity, to have an accelerated entry into an independent research career. It is also an opportunity for research intensive institutions to invigorate their research departments by recruiting outstanding, early career scientists. There is a limit of TWO candidates per institution.
Internal Deadline: November 26
LOI Deadline: December 30
Full Application: January 30, 2013
| EVENTS
September 17
Pathology Research Seminar Series
Anjon Audhya, PhD
Assistant Professor, Biomolecular Chemistry
University of Wisconsin, Madison
Topic: Regulatory Mechanisms that Control Vesicle Biogenesis: Connections to Oncogenesis
12 pm Frohring Auditorium – BRB 105
Physiology and Biophysics Seminar
Frederick J. Sigworth, PhD
Professor, Cellular & Molecular Physiology and Biomedical Engineering
Yale University
Topic: Cryo-EM Study of a Membrane Protein in a Membrane: the BK Potassium Channel
4 pm SOM / Robbins Building, E-501
September 18
Pharmacology Invited Seminar
Douglas Marchuk, PhD
Professor and Vice Chair, Molecular Genetics and Microbiology
Duke University
Topic: Cerebral Cavernous Malformations: The Road from Gene Discovery to Potential Therapy
10 am Webster Conference Rm, W331
September 19
Hematology and Oncology Division Research Conference
Rom Leidner, MD
Instructor, Div. of Hem/Onc
CWRU/UH
Topic: Esophageal Cancer Overview
8 am Lerner Tower B-151
September 20
Stem Cell Biology and Regenerative Medicine
Fabio Rossi, MD, PhD
Professor, Medical Genetics
Biomedical Research Centre
Topic: The Role of Blood Derived Monocytes in Neuroinflammatory Disease
1 pm NE1-205 Cleveland Clinic
September 21
Cancer Center Research in Progress canceled
Hematology/Oncology Special Conference
Michael Gibson, MD, PhD
Assistant Professor, Div. of Hem/Onc
University of Pittsburgh
Topic: TBD
8 am Wearn 137
Cell Biology Seminar Series
Markus Bredel, MD, PhD
Associate Professor, Radiation Oncology
University of Alabama at Birmingham
Topic: TBD
10 am NC1-202 Cleveland Clinic
Cancer Center Seminar Series
Bing-Cheng Wang, PhD
Professor, Medicine
CWRU/MetroHealth Medical Center
Topic: Mechanism-Driven and Structure-Based Approaches to Developing Small Molecules Targeting EphA2 in Cancer
12 pm Frohring Auditorium – BRB 105
Case CCC Calendar
LRI Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Imaging Solutions in Cancer Management: A Case-based Conference
September 21
Wolstein Research Building
Brochure
Registration
National GvHD Health Symposium
November 2
Embassy Suites Cleveland-Rockside
Details
Registration
ADDITIONAL UPCOMING SEMINARS & EVENTS
Ninth International Conference of the Society for Integrative Oncology
October 8-10
Albuquerque, NM
Details
Biennial Science of Global Prostate Cancer Disparities conference
November 1-4
Nassau, The Bahamas
Details
The Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA
November 27-28
Crystal City, Virginia
Details
Deadline to submit abstracts: October 5
American Society of Hematology (ASH) Annual Meeting
December 8-11
Atlanta, Georgia
Details
Pacific Symposium on Biocomputing 2013
January 3-7, 2013
Fairmont Orchid, Hawaii
Details
|
